Influenza virus sialidase - A drug discovery target /
<p>Influenza continues to be an ongoing problem despite the existence of vaccines and drugs. Disease outbreaks can occur relatively quickly as witnessed with the recent emergence of the influenza virus A/H1N1 pandemic. The development of new anti-influenza drugs is thus a major challenge. <...
Guardat en:
| Autor corporatiu: | |
|---|---|
| Altres autors: | |
| Format: | eBook |
| Idioma: | English |
| Publicat: |
Basel :
Springer Base,
2012.
|
| Col·lecció: | Milestones in Drug Therapy
|
| Matèries: | |
| Accés en línia: | Click here to view the full text content |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|
| Sumari: | <p>Influenza continues to be an ongoing problem despite the existence of vaccines and drugs. Disease outbreaks can occur relatively quickly as witnessed with the recent emergence of the influenza virus A/H1N1 pandemic. The development of new anti-influenza drugs is thus a major challenge. </p><p>This volume describes all aspects of the virus structure and function relevant to infection. The focus is on drug discovery of inhibitors to the enzyme sialidase, which plays a key role in the infectious lifecycle of the virus. Following an overview of the influenza virus, the<b> </b>haemagglutinin, the interactions with the cell receptors and the enzymology of virus sialidase, recent results in drug design are presented. These include a full coverage of the design, synthesis and evaluation of carbohydrate as well as non-carbohydrate influenza virus sialidase inhibitors. Further reviews of the clinical experience with influenza virus sialidase inhibitors and of the development of resistance to these inhibitor drugs complement the topic.</p> |
|---|---|
| Descripció física: | 1 Online resource (IX, 178 pages) 58 illustration, 21 illustration in color, digital. |
| ISBN: | 9783764389277 |